Hydrogen Research Study
← Back to Research Library
Human clinical evidenceCase ReportOther or not reported

Molecular Hydrogen Reverses Sepsis-induced Immunoparalysis: Insights from Longitudinal Deep Immunophenotyping.

Chang-Lung Wu, Jeng-Wei Lu, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Kuang-Yih Wang, Feng-Cheng Liu · In vivo (Athens, Greece) · 2026

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Sepsis and Critical Care
Evidence type Human clinical evidence
Publication type Case Report
Hydrogen method Other or not reported

How Molecular Hydrogen Was Used

However, longitudinal evidence on the effects of molecular hydrogen on deep human immunophenotyping remains scarce. At a therapeutic impasse marked by high levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) (>35,000 pg/ml) and profound immune depletion, adjuvant hydrogen inhalation was initiated, which led to a 64% reduction in myocardial stress and temporary clinical stabilization. In the T-cell compartment, hydrogen induced a biphasic resolution of exhaustion in T-helper cells marked by an immediate decline in expression of FAS cell surface death receptor (FAS; also known as CD95) and asynchronous normalization of expression of programmed cell death protein 1 (PD1) and T-cell immunoglobulin and mucin domain 3 (TIM3), alongside bidirectional restoration of physiological immune checkpoints in cytotoxic T-cells.

What the Researchers Found

At a therapeutic impasse marked by high levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) (>35,000 pg/ml) and profound immune depletion, adjuvant hydrogen inhalation was initiated, which led to a 64% reduction in myocardial stress and temporary clinical stabilization.

H₂ Mechanisms / Biological Findings

In the T-cell compartment, hydrogen induced a biphasic resolution of exhaustion in T-helper cells marked by an immediate decline in expression of FAS cell surface death receptor (FAS; also known as CD95) and asynchronous normalization of expression of programmed cell death protein 1 (PD1) and T-cell immunoglobulin and mucin domain 3 (TIM3), alongside bidirectional restoration of physiological immune checkpoints in cytotoxic T-cells.

Authors’ Conclusion

By disrupting the cycle of immune exhaustion and exerting anti-apoptotic effects, molecular hydrogen may represent a promising immunomodulatory adjunct in severe sepsis.

H2HUBB TAKEAWAY

In this case report, adjunctive hydrogen inhalation was followed by temporary clinical stabilization and longitudinal immune changes in a 49-year-old man with refractory septic shock. The report described the patient's death from irreversible chronic comorbidities. This single case suggests possible immunomodulatory potential, while controlled clinical studies are needed to determine safety and effectiveness.

What the Researchers Studied

The study examined in the T-cell compartment, hydrogen induced a biphasic resolution of exhaustion in T-helper cells marked by an immediate decline in expression of FAS cell surface death receptor (FAS.

Case-Report Evidence Boundary

The report described the patient's death from irreversible chronic comorbidities. This single case suggests possible immunomodulatory potential, while controlled clinical studies are needed to determine safety and effectiveness.